This 2010 article by Mikhail V. Blagosklonny proposes a translational framework to extend healthy lifespan by pharmacologically suppressing aging. The author introduces the concept of "post-aging syndrome," where age-related diseases are delayed or prevented through targeted interventions. Central to this approach is the inhibition of the mTOR pathway, which is
